title: Complete molecular remission induced by concomitant cladribine--rituximab treatment in a case of multi-resistant hairy cell leukemia.
authors: Francesco
authors: F
authors: Forconi
authors: Francesca
authors: F
authors: Toraldo
authors: Elisa
authors: E
authors: Sozzi
authors: Teresa
authors: T
authors: Amato
authors: Donatella
authors: D
authors: Raspadori
authors: Francesco
authors: F
authors: Lauria
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017338:Cladribine / Q000008:administration & dosage*; D019008:Drug Resistance, Neoplasm; D006801:Humans; D007143:Immunoglobulin Heavy Chains / Q000235:genetics; D007135:Immunoglobulin Variable Region / Q000235:genetics; D007943:Leukemia, Hairy Cell / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007143:Immunoglobulin Heavy Chains; D007135:Immunoglobulin Variable Region; D017338:Cladribine; D000069283:Rituximab